PMID- 31901598 OWN - NLM STAT- MEDLINE DCOM- 20210818 LR - 20210818 IS - 1096-0023 (Electronic) IS - 1043-4666 (Linking) VI - 127 DP - 2020 Mar TI - Interactions among thyroid hormone (FT(4)), chemokine (MCP-1) and neurotrophin (NGF-beta) levels studied in Hungarian postmenopausal and obese women. PG - 154948 LID - S1043-4666(19)30377-1 [pii] LID - 10.1016/j.cyto.2019.154948 [doi] AB - Thyroid dysfunction is more frequent in postmenopause and metabolic syndrome characterized by increased proinflammatory cytokines (IL-1, IL-6, TNFalpha), insulin resistance and overweight. Serum levels of monocyte chemoattractant protein-1 (MCP-1) chemokine and nerve growth factor-beta (NGF-beta) and their effects were studied on thyroid hormone levels in 133 Hungarian women (postmenopausal 66, obese 32, control 35). MCP-1 and NGF-beta levels were measured with enzyme-linked, and thyroid hormones with chemiluminescence immunoassays. Subclinical hypothyroidism in postmenopause (7/66 vs 1/32 cases) and the presence of low FT(4) levels in obese women were more frequent (6/32 vs 2/66 cases, p < 0.0447). Obese women showed reduced serum FT(4) and higher MCP-1 or NGF-beta levels compared to those in postmenopausal women [geometric mean (95%CI): 13.6 (10.9-21.69) vs 15.37 (9.06-20.42) pmol/l, p < 0.003 for FT(4), and 19.36 (14.27-26.26) vs 17.29 (12.65-23.63) ng/ml, p < 0.0013 for MCP-1 or 18.64 (6.8-51.11) vs 14.01 (8.59-22.83) ng/ml, p < 0.0003 for NGF-beta]. Serum FT(4) levels inversely associated with MCP-1 (p < 0.0023, r = -0.1971) or estradiol levels (p < 0.0286, r = -0.1913), and positively associated with age (p < 0.0175, r = 0.2058). As opposed to estradiol and NGF-beta levels, BMI had no effects on serum FT(4) levels in postmenopausal and obese women forming 3 subgroups displaying only MCP-1, both MCP-1 and NGF-beta positivities or no positivities at all. In summary, not only proinflammatory cytokines, but also MCP-1 chemokine and NGF-beta levels can play a role in reduced serum FT(4) levels in postmenopausal and obese women. Particularly, the decreased FT(4) levels were connected to both increased MCP-1 and NGF-beta levels in obese women. CI - Copyright (c) 2020 Elsevier Ltd. All rights reserved. FAU - Molnar, Ildiko AU - Molnar I AD - Immunoendocrinology, EndoMed, Bem ter 18/C., Debrecen 4026, Hungary. Electronic address: molil@endomed.hu. LA - eng PT - Journal Article DEP - 20191231 PL - England TA - Cytokine JT - Cytokine JID - 9005353 RN - 0 (CCL2 protein, human) RN - 0 (Chemokine CCL2) RN - 0 (Cytokines) RN - 0 (NGF protein, human) RN - 0 (Thyroid Hormones) RN - 9061-61-4 (Nerve Growth Factor) SB - IM MH - Body Mass Index MH - Chemokine CCL2/*blood MH - Cytokines/blood MH - Female MH - Humans MH - Hungary MH - Inflammation/blood MH - Metabolic Syndrome/blood MH - Nerve Growth Factor/*blood MH - Obesity/*blood MH - Postmenopause/*blood MH - Thyroid Gland/metabolism MH - Thyroid Hormones/*blood OTO - NOTNLM OT - Free thyroxine levels OT - Monocyte chemoattractant protein-1 OT - Nerve growth factor OT - Obesity OT - Postmenopause COIS- Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. EDAT- 2020/01/07 06:00 MHDA- 2021/08/19 06:00 CRDT- 2020/01/06 06:00 PHST- 2019/08/19 00:00 [received] PHST- 2019/11/23 00:00 [revised] PHST- 2019/12/02 00:00 [accepted] PHST- 2020/01/07 06:00 [pubmed] PHST- 2021/08/19 06:00 [medline] PHST- 2020/01/06 06:00 [entrez] AID - S1043-4666(19)30377-1 [pii] AID - 10.1016/j.cyto.2019.154948 [doi] PST - ppublish SO - Cytokine. 2020 Mar;127:154948. doi: 10.1016/j.cyto.2019.154948. Epub 2019 Dec 31.